NeOnc Technologies to discuss Phase 2a glioma trial results Aug. 12
Tweet Send to a Friend
NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) announced it will host an investor conference call on August 12, 2026, at 5:30 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


